These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11063822)

  • 1. Significant correlation between IL-10 levels and IgG indices in the cerebrospinal fluid of patients with multiple sclerosis.
    Nakashima I; Fujihara K; Misu T; Okita N; Takase S; Itoyama Y
    J Neuroimmunol; 2000 Nov; 111(1-2):64-7. PubMed ID: 11063822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.
    Ragheb S; Li Y; Simon K; VanHaerents S; Galimberti D; De Riz M; Fenoglio C; Scarpini E; Lisak R
    Mult Scler; 2011 Jul; 17(7):819-29. PubMed ID: 21372118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8.
    Kleine TO; Zwerenz P; Graser C; Zöfel P
    Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and intrathecal IgG synthesis in multiple sclerosis patients during clinical remission.
    Brandão CO; Ruocco HH; Farias Ados S; Oliveira C; Hallal-Longo DE; Mirandola SR; Oliveira EC; Cendes F; Damasceno BP; Santos LM
    Arq Neuropsiquiatr; 2005 Dec; 63(4):914-9. PubMed ID: 16400404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.
    Fainardi E; Rizzo R; Melchiorri L; Vaghi L; Castellazzi M; Marzola A; Govoni V; Paolino E; Tola MR; Granieri E; Baricordi OR
    J Neuroimmunol; 2003 Sep; 142(1-2):149-58. PubMed ID: 14512174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the IgG index and oligoclonal bands in the cerebrospinal fluid of patients with multiple sclerosis.
    Mares J; Herzig R; Urbanek K; Sladkova V; Sklenarova J; Bekarek V; Schneiderka P; Zapletalova J; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Dec; 152(2):247-9. PubMed ID: 19219215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
    Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
    J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
    Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
    JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles.
    Malmeström C; Andersson BA; Haghighi S; Lycke J
    J Neuroimmunol; 2006 Jun; 175(1-2):176-82. PubMed ID: 16626811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of intrathecal oligoclonal B cells and IgG in multiple sclerosis.
    Tomescu-Baciu A; Johansen JN; Holmøy T; Greiff V; Stensland M; de Souza GA; Vartdal F; Lossius A
    J Neuroimmunol; 2019 Aug; 333():576966. PubMed ID: 31153015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untreated relapsing remitting multiple sclerosis patients show antibody production against latent Epstein Barr Virus (EBV) antigens mainly in the periphery and innate immune IL-8 responses preferentially in the CNS.
    Sisay S; Lopez-Lozano L; Mickunas M; Quiroga-Fernández A; Palace J; Warnes G; Alvarez-Lafuente R; Dua P; Meier UC
    J Neuroimmunol; 2017 May; 306():40-45. PubMed ID: 28385186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alfa and interleukin-4 in cerbrospinal fluid and plasma in different clinical forms of multiple sclerosis.
    Obradović D; Kataranovski M; Dincić E; Obradović S; Colić M
    Vojnosanit Pregl; 2012 Feb; 69(2):151-6. PubMed ID: 22500369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral imbalanced TFH/TFR ratio correlates with intrathecal IgG synthesis in multiple sclerosis at clinical onset.
    Puthenparampil M; Zito A; Pantano G; Federle L; Stropparo E; Miante S; De Silvestro G; Plebani M; Gallo P
    Mult Scler; 2019 Jun; 25(7):918-926. PubMed ID: 29882478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
    Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
    Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis.
    Verbeek MM; Notting EA; Faas B; Claessens-Linskens R; Jongen PJ
    Acta Neurol Scand; 2010 May; 121(5):309-14. PubMed ID: 19925532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid biomarkers for predicting development of multiple sclerosis in acute optic neuritis: a population-based prospective cohort study.
    Olesen MN; Soelberg K; Debrabant B; Nilsson AC; Lillevang ST; Grauslund J; Brandslund I; Madsen JS; Paul F; Smith TJ; Jarius S; Asgari N
    J Neuroinflammation; 2019 Mar; 16(1):59. PubMed ID: 30857557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal synthesis in particular types of multiple sclerosis.
    Sladkova V; Mares J; Hlustik P; Langova J; Kanovsky P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):124-6. PubMed ID: 23073520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis.
    Peiravian F; Rajaian H; Samiei A; Gholijani N; Gharesi-Fard B; Mokaram P; Rahimi-Jaberi A; Kamali Sarvestani E
    Iran J Immunol; 2016 Sep; 13(3):186-96. PubMed ID: 27671510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.